Director received an award of 7,490 BMRN shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 2, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 4, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001628280-26-040907
- Filed / recorded
Jun 4, 2026, 10:02 PM UTCAdded to OQROOct 6, 2026, 4:40 PM UTC Data qualityVerified: identifiers matched exactly IssuerBIOMARIN PHARMACEUTICAL INC Reporting personBarbara W. Bodem TableNon-derivative (Table I) Transaction dateJun 2, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Restricted stock units granted on June 2, 2026. Price not applicable.
Around the same time
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.